Adverse events of unapproved drugs in Japan

被引：2
作者：
Miyakoshi, Shigesaburo [1 ]
Kusumi, Eiji [2 ]
Kodama, Yuko [2 ]
Narimatsu, Hiroto [2 ]
Hamaki, Tamae [2 ]
Matsumura, Tomoko [2 ]
Kami, Masahiro [2 ]
机构：
[1] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan
[2] Univ Tokyo, Inst Med Sci, Div Exploratory Res, Tokyo, Japan
来源：
LANCET ONCOLOGY | 2008年 / 9卷 / 05期
关键词：
D O I：
10.1016/S1470-2045(08)70116-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：414 / 415
页数：2
相关论文
共 50 条
  • [41] Epidemiology of adverse drug events and medication errors in four nursing homes in Japan: the Japan Adverse Drug Events (JADE) Study
    Ayani, Nobutaka
    Oya, Nozomu
    Kitaoka, Riki
    Kuwahara, Akiko
    Morimoto, Takeshi
    Sakuma, Mio
    Narumoto, Jin
    [J]. BMJ QUALITY & SAFETY, 2022, 31 (12) : 878 - 887
  • [42] Currents in contemporary ethics the implications of expanding access to unapproved drugs - The implications of expanding access to unapproved drugs
    Talbott, Meghan K.
    [J]. JOURNAL OF LAW MEDICINE & ETHICS, 2007, 35 (02) : 316 - 319
  • [43] Risk management of unapproved drugs in Japan: An academic activity for safety data exchange via the internet
    Sato, Tsugumichi
    Kiuchi, Takahiro
    Aoki, Noriaki
    Watanabe, Hikaru
    Kubota, Kiyoshi
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S182 - S183
  • [44] Microbiological contamination in counterfeit and unapproved drugs
    Dieter Pullirsch
    Julie Bellemare
    Andreas Hackl
    Yvon-Louis Trottier
    Andreas Mayrhofer
    Heidemarie Schindl
    Christine Taillon
    Christian Gartner
    Brigitte Hottowy
    Gerhard Beck
    Jacques Gagnon
    [J]. BMC Pharmacology and Toxicology, 15
  • [45] Microbiological contamination in counterfeit and unapproved drugs
    Pullirsch, Dieter
    Bellemare, Julie
    Hackl, Andreas
    Trottier, Yvon-Louis
    Mayrhofer, Andreas
    Schindl, Heidemarie
    Taillon, Christine
    Gartner, Christian
    Hottowy, Brigitte
    Beck, Gerhard
    Gagnon, Jacques
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2014, 15
  • [46] PRESCRIBING DRUGS FOR USES UNAPPROVED BY FDA
    WISE, RI
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 224 (07): : 1040 - 1040
  • [47] Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients The Japan Adverse Drug Events Study
    Ayani, Nobutaka
    Morimoto, Takeshi
    Sakuma, Mio
    Kikuchi, Toshiaki
    Watanabe, Koichiro
    Narumoto, Jin
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2021, 41 (04) : 397 - 402
  • [48] Polypharmacy, Inappropriate Prescribing and Adverse Drug Events in Japan
    Tokuda, Yasuharu
    [J]. JOURNAL OF GENERAL AND FAMILY MEDICINE, 2016, 17 (01): : 3 - 4
  • [49] A Personalized and Learning Approach for Identifying Drugs with Adverse Events
    Shin, Sug Kyun
    Hur, Ho
    Cheon, Eun Kyung
    Oh, Ock Hee
    Lee, Jeong Seon
    Ko, Woo Jin
    Kim, Beom Seok
    Kwon, YoungOk
    [J]. YONSEI MEDICAL JOURNAL, 2017, 58 (06) : 1229 - 1236
  • [50] ADVERSE EVENTS OF BIOLOGICAL DRUGS IN SPONDYLOARTHRITIS, DOMINICAN REPUBLIC
    Jimenez-Candelaria, R.
    Marte-Robles, M.
    Concepcion-Sanchez, L.
    Rosario-Guzman, E.
    Rodriguez-Bautista, E.
    Rosario, V.
    Munoz-Louis, R.
    Valdez-Lorie, T.
    Alba-Feriz, R.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S63 - S63
12345